NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.

Curtis, William M; Seeds, William A; Mattson, Mark P; Bradshaw, Patrick C

Curtis, William M; Seeds, William A; Mattson, Mark P; Bradshaw, Patrick C.

Afiliación

Curtis WM; Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.
Seeds WA; Seeds Scientific Performance Research, Spire Institute, Geneva, OH 44041, USA.
Mattson MP; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Bradshaw PC; Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.

Cells ; 11(15)2022 08 04.

Article en En | MEDLINE | ID: mdl-35954260

Asunto(s)

Enfermedad de Parkinson; Terapia por Ejercicio; Ayuno; Humanos; Mitocondrias/metabolismo; NAD/metabolismo; NADP/metabolismo; Enfermedad de Parkinson/metabolismo; Ácido Peroxinitroso/metabolismo; Superóxidos/metabolismo

Palabras clave

DJ-1; IDH1; NAD; NADPH; PINK1; Parkin; Parkinson's disease; circadian; coffee; exercise; fasting; metabolic therapy; mitochondrial biogenesis; mitochondrial quality control; mitophagy; nicotinamide adenine dinucleotide; nicotinamide adenine dinucleotide phosphate

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google